期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

食管癌预后有关的分子生物学标记物 被引量：3

Advances in biological markers on prognosis of esophageal cancer
下载PDF
导出
摘要 近来 ,分子生物学研究的飞速发展 ,为我们能更好地预测食管癌的预后、改进治疗方法和提高生存率提供了可能。在此 ,作者就近年来与食管癌预后有关的分子生物学标记物的研究作一综述。 With the development of molecular biology,the study of biological markers will probably help to predict the prognosis and to improve the method of treatment and the survival. Advances in biological markers of esophageal cancer prognosis were reviewed. [
作者 赵快乐 施学辉 蒋国梁
机构地区 复旦大学附属肿瘤医院放疗科
出处 《中国癌症杂志》 CAS CSCD 2001年第3期273-275,共3页 China Oncology
关键词 食管癌 生物学标记物 预后 esophageal carcinoma biological marker prognosis
分类号 R735.1 [医药卫生—肿瘤]
  • 相关文献

参考文献19

  • 1[1]Sarbia M, Proschen R, Borchard F, et al. P53 protein expression and prognosis in squamous cell carcinoma of the esophagus [J].Cancer, 1994,74(8): 2218-2223.
  • 2[2]Coggi G, Bosari S, Roncalli M, et al. P53 protein accumulation and P53 gene mutation in esophageal carcinoma, A molecular and immunohistochemical study with clinicopathologic correlations [J].Cancer, 1997,79(3) :425-432.
  • 3[3]Kobayashi S, Koide Y, Endo M, et al. The p53 mutation is of prognostic value in esophageal squamous cell carcinoma patients in unified stages of curability [ J ]. Am J Surg , 1999,, 177 ( 6 ): 497-502.
  • 4[4]Ribeiro U Jr. Sydney D, Finkelstein V, et al. P53 sequence analysis predicts treatment response and out come of patients with esophageal carcinoma[J]. C 1998,83(1): 7-18.
  • 5[5]Schlichtholz B, Legros Y, Gillet D, et al. The immune response to P53 in breast cancer patients is directed against immunodominant epitopes unrelated to the mutational hot spot[J]. Cancer Res, 1992,52(22): 6380-6384.
  • 6[6]Wild CP, Ridanpa M, Anttila S, et al. Adhesion receptors in malignant transformation and dissemination of gastrointestinal tumors[J]. Cancer, 1995,64( 1 ): 176-181.
  • 7[7]Serramo M, Hannon GJ, Beach DA. A new regulatory modified in cell-cycle control causing specific inhibition of cyclinD/CDK4 [J]. Nature, 1993,366(2): 704-704.
  • 8[8]Gramlich TL, Fritseh CR, Maurer D, et al. Differential polymerase chain reaction assay of cvclinD1 gene amplification in esophageal carcinoma[J]. Diag Mol Pathol, 1994,3(2) ;255-259.
  • 9[9]Naitoh H. Overexpression and localization of cyclinD1 mRNA and antigen in esophageal cancer[ J]. Am J Pathol, 1995,45(1):239-245.
  • 10[10]Mukaida H, Toi M, Hirai T, et al. Clinical significance of the expression of epidermal growth factor and its receptor in esophageal cancer[J]. Cancer, 1991 ,68( 1): 142-148.

同被引文献6

引证文献3

二级引证文献9

中国癌症杂志
2001年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部